Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Jul 21, 2021 3:03pm
104 Views
Post# 33582409

RE:Insider Buying?

RE:Insider Buying?Very, very good question!!!

They work for Th, earn their money and when the company comes in the need
of money, they will do an offering again at whatever "terms" it suits them!! 
Because it is of no intrest to them if they raise at 4 or 6 or 8.........They don't care because, except of their job, they have no direct intrest!!! 

I really hope they succeed with their platform and can give new hope for patients who are in need, but to let go all the great catalists without a single price increase is out of my least imagination in such a great bull market! 

Good luck all (glad i sold those shares for now, thx to whoever bought them.....) 



Kd5513
Insider Buying?

Does anyone know the schedule when BOD and execs can purchase THTX?

With all of the promising news on cancer and fair news on NASH, I would expect shares to be picked up if PH1 is going as well as what many are thinking here.
<< Previous
Bullboard Posts
Next >>